PortfoliosLab logoPortfoliosLab logo
High Beta - Max Sharpe Optimization
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Diversification

Asset Allocation


LLY 31.90%NVO 31.90%ACGL 16.70%AVGO 7.60%NVDA 6.00%2 positions 5.90%EquityEquity

S&P 500 Index

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in High Beta - Max Sharpe Optimization, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends. The portfolio is rebalanced Every 3 months.


Loading graphics...

The earliest data available for this chart is Sep 22, 2016, corresponding to the inception date of ELF

Returns By Period


1D1MYTD6M1Y3Y*5Y*10Y*
Benchmark
S&P 500 Index
0.11%-3.43%-3.84%-1.98%16.08%16.86%10.37%12.29%
Portfolio
High Beta - Max Sharpe Optimization
0.13%-3.64%-13.90%-9.66%-1.26%21.46%31.20%
LLY
Eli Lilly and Company
-1.98%-7.16%-12.80%14.47%15.19%39.72%39.64%31.19%
NVO
Novo Nordisk A/S
1.37%4.40%-24.78%-34.84%-43.28%-20.60%3.97%5.03%
ACGL
Arch Capital Group Ltd.
1.31%-3.72%0.85%8.60%-0.08%14.03%20.89%15.54%
AVGO
Broadcom Inc.
0.34%0.44%-8.93%-6.61%84.26%72.07%48.84%38.50%
NVDA
NVIDIA Corporation
0.93%-1.47%-4.88%-6.08%60.69%85.17%66.71%70.07%
SMCI
Super Micro Computer, Inc.
3.15%-24.32%-20.67%-55.77%-33.83%27.24%42.44%21.17%
ELF
e.l.f. Beauty, Inc.
-1.83%-24.58%-19.57%-55.00%-9.91%-9.78%17.82%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Monthly Returns

Based on dividend-adjusted daily data since Sep 23, 2016, High Beta - Max Sharpe Optimization's average daily return is +0.10%, while the average monthly return is +2.09%. At this rate, your investment would double in approximately 2.8 years.

Historically, 67% of months were positive and 33% were negative. The best month was Feb 2024 with a return of +14.3%, while the worst month was Mar 2025 at -12.7%. The longest winning streak lasted 12 consecutive months, and the longest losing streak was 5 months.

On a daily basis, High Beta - Max Sharpe Optimization closed higher 55% of trading days. The best single day was Mar 26, 2020 with a return of +9.2%, while the worst single day was Mar 16, 2020 at -10.9%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
20264.39%-12.14%-7.24%1.20%-13.90%
2025-0.55%7.14%-12.67%1.35%3.40%3.66%-10.82%4.80%2.76%1.57%8.19%-0.12%6.56%
202413.62%14.32%6.48%-1.03%6.93%7.48%-7.89%9.76%-7.28%-6.52%-0.75%-5.28%29.60%
20231.45%2.68%9.65%8.35%8.26%6.88%1.56%11.83%-3.11%3.30%5.95%1.03%74.24%
2022-8.77%1.61%8.94%-2.13%3.38%-1.50%4.70%-5.11%-2.54%13.54%10.65%2.07%24.99%
20214.86%3.49%-2.73%3.76%5.68%8.08%5.62%6.95%-6.55%11.91%0.19%7.83%59.65%

Benchmark Metrics

High Beta - Max Sharpe Optimization has an annualized alpha of 15.68%, beta of 0.85, and R² of 0.49 versus S&P 500 Index. Calculated based on daily prices since September 23, 2016.

  • This portfolio captured 121.79% of S&P 500 Index gains but only 62.10% of its losses — a favorable profile for investors.
  • R² of 0.49 means the benchmark explains less than half of this portfolio's behavior — treat beta with caution or consider switching to a more representative benchmark.

Alpha
15.68%
Beta
0.85
0.49
Upside Capture
121.79%
Downside Capture
62.10%

Expense Ratio

High Beta - Max Sharpe Optimization has an expense ratio of 0.00%, meaning no management fees are charged. Below, you can find the expense ratios of the portfolio's funds side by side and easily compare their relative costs.


The portfolio doesn't include any funds that charge management fees.

Return for Risk

Risk / Return Rank

High Beta - Max Sharpe Optimization ranks 5 for risk / return — in the bottom 5% of portfolios on our site. This means you're taking on significantly more risk than the returns justify. Consider whether the potential upside is worth the volatility, or explore alternatives with better risk / return profiles.


High Beta - Max Sharpe Optimization Risk / Return Rank: 55
Overall Rank
High Beta - Max Sharpe Optimization Sharpe Ratio Rank: 44
Sharpe Ratio Rank
High Beta - Max Sharpe Optimization Sortino Ratio Rank: 44
Sortino Ratio Rank
High Beta - Max Sharpe Optimization Omega Ratio Rank: 44
Omega Ratio Rank
High Beta - Max Sharpe Optimization Calmar Ratio Rank: 66
Calmar Ratio Rank
High Beta - Max Sharpe Optimization Martin Ratio Rank: 55
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics


PortfolioBenchmarkDifference

Sharpe ratio

Return per unit of total volatility

-0.04

0.88

-0.93

Sortino ratio

Return per unit of downside risk

0.13

1.37

-1.23

Omega ratio

Gain probability vs. loss probability

1.02

1.21

-0.19

Calmar ratio

Return relative to maximum drawdown

-0.01

1.39

-1.40

Martin ratio

Return relative to average drawdown

-0.02

6.43

-6.46


How much return does each position deliver for the risk it carries? Higher values mean better reward for the risk taken.

Risk / Return RankSharpe ratioSortino ratioOmega ratioCalmar ratioMartin ratio
LLY
Eli Lilly and Company
510.360.781.110.561.37
NVO
Novo Nordisk A/S
11-0.80-0.970.87-0.78-1.35
ACGL
Arch Capital Group Ltd.
37-0.000.161.020.050.10
AVGO
Broadcom Inc.
841.762.491.323.087.50
NVDA
NVIDIA Corporation
811.472.171.273.027.54
SMCI
Super Micro Computer, Inc.
23-0.43-0.140.98-0.51-1.01
ELF
e.l.f. Beauty, Inc.
36-0.130.331.05-0.08-0.16

Sharpe Ratio

The Sharpe ratio helps investors understand how much return they're getting for the level of risk taken. A higher Sharpe ratio indicates better risk-adjusted performance, meaning more reward for each unit of risk.

High Beta - Max Sharpe Optimization Sharpe ratios as of Apr 3, 2026 (values are recalculated daily):

  • 1-Year: -0.04
  • 5-Year: 1.33
  • All Time: 1.19

These values reflect how efficiently the investment has delivered returns relative to its volatility over different time periods. All figures are annualized and based on daily total returns (including price changes and dividends).

Compared to the broad market, where average Sharpe ratios range from 1.00 to 1.68, this portfolio's current Sharpe ratio places it in the bottom 25%. This suggests weaker risk-adjusted returns than most portfolios, possibly due to lower returns, higher volatility, or both. It may be worth reviewing the allocation. You can use the Portfolio Optimization tool to explore options for improving the Sharpe ratio.

The chart below shows the rolling Sharpe ratio of High Beta - Max Sharpe Optimization compared to the selected benchmark. This view highlights how the investment's risk-adjusted performance has changed over time.


Loading graphics...

Dividends

Dividend yield

High Beta - Max Sharpe Optimization provided a 1.83% dividend yield over the last twelve months.


TTM20252024202320222021202020192018201720162015
Portfolio1.83%1.29%1.73%0.70%0.96%1.00%1.39%1.59%1.35%1.43%1.94%1.21%
LLY
Eli Lilly and Company
0.67%0.56%0.67%0.78%1.07%1.23%1.75%1.96%1.94%2.46%2.77%2.37%
NVO
Novo Nordisk A/S
4.87%3.31%1.68%1.00%1.20%1.35%1.87%2.14%1.45%1.52%2.87%0.92%
ACGL
Arch Capital Group Ltd.
0.00%0.00%5.41%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
AVGO
Broadcom Inc.
0.79%0.70%0.94%1.71%3.02%2.24%3.05%3.54%3.11%1.87%1.43%1.13%
NVDA
NVIDIA Corporation
0.02%0.02%0.03%0.03%0.11%0.05%0.12%0.27%0.46%0.29%0.45%1.20%
SMCI
Super Micro Computer, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
ELF
e.l.f. Beauty, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading graphics...

Worst Drawdowns

The table below displays the maximum drawdowns of the High Beta - Max Sharpe Optimization. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the High Beta - Max Sharpe Optimization was 33.20%, occurring on Apr 8, 2025. The portfolio has not yet recovered.

The current High Beta - Max Sharpe Optimization drawdown is 25.93%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-33.2%Jul 11, 2024187Apr 8, 2025
-28.13%Feb 20, 202023Mar 23, 202053Jun 8, 202076
-13.47%Dec 16, 202128Jan 26, 202242Mar 28, 202270
-13.27%Jan 29, 20189Feb 8, 2018124Aug 7, 2018133
-12.65%Aug 26, 202221Sep 26, 202224Oct 28, 202245

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading graphics...

Diversification

Diversification Metrics


Number of Effective Assets

The portfolio contains 7 assets, with an effective number of assets of 4.12, reflecting the diversification based on asset allocation. This number of effective assets suggests a highly concentrated portfolio, where a few assets dominate the allocation, potentially increasing the portfolio's risk due to lack of diversification.

Asset Correlations Table

The table below displays the correlation coefficients between the individual components of the portfolio, the entire portfolio, and the chosen benchmark.

BenchmarkACGLELFLLYNVOSMCINVDAAVGOPortfolio
Benchmark1.000.400.420.360.360.450.640.660.65
ACGL0.401.000.210.200.170.170.140.170.42
ELF0.420.211.000.160.170.300.290.300.37
LLY0.360.200.161.000.420.180.190.210.73
NVO0.360.170.170.421.000.190.240.240.74
SMCI0.450.170.300.180.191.000.420.400.42
NVDA0.640.140.290.190.240.421.000.630.49
AVGO0.660.170.300.210.240.400.631.000.50
Portfolio0.650.420.370.730.740.420.490.501.00
The correlation results are calculated based on daily price changes starting from Sep 23, 2016